Netta Blondheim-Shraga
Chief Tech/Sci/R&D Officer at BRAINSTORM CELL THERAPEUTICS INC.
Profile
Netta Blondheim-Shraga is currently the Vice President-Research & Development at Brainstorm Cell Therapeutics, Inc. She previously worked as a Study Director at Crown Bioscience, Inc. from 2019 to 2020.
Dr. Blondheim-Shraga has a graduate degree from Tel-Aviv University, an undergraduate degree from The Hebrew University of Jerusalem, and a doctorate from Bar-Ilan University and the Faculty of Medicine.
Netta Blondheim-Shraga active positions
| Companies | Position | Start |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2022-05-11 |
Former positions of Netta Blondheim-Shraga
| Companies | Position | End |
|---|---|---|
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 2020-08-31 |
Training of Netta Blondheim-Shraga
| Tel-Aviv University | Graduate Degree |
| The Hebrew University of Jerusalem | Undergraduate Degree |
| Bar-Ilan University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
- Stock Market
- Insiders
- Netta Blondheim-Shraga